Researchers continue to excited about this new drug, a novel dual agonist showing significant results in early trials for weight reduction . It functions by targeting several pathways : GLP-1 and GIP, https://zaynabmejr114127.bloggerchest.com/40912202/a-new-possibility-for-size-management